Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single-arm, phase 2 trial (RJ-AML 2014).
Am J Hematol
; 97(1): 43-51, 2022 01 01.
Article
en En
| MEDLINE
| ID: mdl-34687467
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Idarrubicina
/
Leucemia Mieloide Aguda
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Citarabina
/
Homoharringtonina
Tipo de estudio:
Diagnostic_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2022
Tipo del documento:
Article